Moderna

News

Moderna's RSV shot gets US nod for use in younger adults

The label for Moderna's RSV vaccine mResvia has been expanded to include adults aged 18 and over in the US, but will that lead to an uptick in sales?

News

Moderna's $760m-plus flu vaccine contracts are nixed by HHS

HHS cancels funding for Moderna's pandemic flu vaccine development in a move viewed by some as an attack on mRNA technology.

News

FDA tightens heart tox warnings on mRNA COVID vaccines

The FDA has instructed Pfizer and Moderna to add stronger warnings to the labels of their COVID-19 vaccines about the risk of cardiotoxicity.

News

There's good news for RSV jab firms at delayed ACIP meeting

GSK and Pfizer could see a resurgence in sales of their RSV vaccines if new recommendations at a CDC expert meeting are confirmed by agency leaders.

News

GSK rides out vaccine sales weakness with cancer, HIV gains

Despite a steep fall-off in sales of RSV vaccine Arexvy last year, GSK has raised its long-term sales forecast to £40 billion in 2031.

News

11 blockbuster drugs to look out for in 2025

Clarivate has revealed 11 drugs due to launch in 2025 that could top $1 billion in annual sales or be clinical 'game changers' in the next five years.

Moderna's RSV shot gets US nod for use in younger adults

Moderna's $760m-plus flu vaccine contracts are nixed by HHS

FDA tightens heart tox warnings on mRNA COVID vaccines

There's good news for RSV jab firms at delayed ACIP meeting

GSK rides out vaccine sales weakness with cancer, HIV gains

11 blockbuster drugs to look out for in 2025

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Moderna

Editor's Picks